Condition

Diabetes Mellitus Complication

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions6

Lead sponsors shown2

Clinical trials

3 shown

MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes MellitusNCT03945747 · 2019-08-14

ACTIVE_NOT_RECRUITING

Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic FunctionNCT03618420 · 2018-10-01

COMPLETED

Accuracy and Treatment Experience of Two Glucose Monitoring Systems Tested in Patients With Type 1 Diabetes and Renal ImpairmentNCT03378271 · 2016-05-05

COMPLETED

Common interventions

Aminohippurate Sodium Inj 20%DRUG1 Blood drawDIAGNOSTIC_TEST1 DXA scanDIAGNOSTIC_TEST1 Iohexol Inj 300 mg/mLDRUG1 Simultanious CGM/FGMDEVICE1 Urine sample collectionDIAGNOSTIC_TEST1

Leading sponsors

University of Colorado, Denver 2 Vastra Gotaland Region 1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

Phase mix

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.